KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutanix (NTNX) Other financing activities: 2015-2025

Historic Other financing activities for Nutanix (NTNX) over the last 8 years, with Oct 2025 value amounting to $68,000.

  • Nutanix's Other financing activities fell 90.90% to $68,000 in Q4 2025 from the same period last year, while for Oct 2025 it was $2.5 million, marking a year-over-year decrease of 68.38%. This contributed to the annual value of $3.4 million for FY2025, which is 18.70% down from last year.
  • Latest data reveals that Nutanix reported Other financing activities of $68,000 as of Q4 2025, which was down 85.05% from $455,000 recorded in Q2 2025.
  • Nutanix's Other financing activities' 5-year high stood at $8.3 million during Q2 2021, with a 5-year trough of $68,000 in Q4 2025.
  • Over the past 3 years, Nutanix's median Other financing activities value was $684,000 (recorded in 2023), while the average stood at $1.1 million.
  • In the last 5 years, Nutanix's Other financing activities spiked by 872.03% in 2021 and then plummeted by 91.08% in 2022.
  • Nutanix's Other financing activities (Quarterly) stood at $1.4 million in 2021, then soared by 46.08% to $2.0 million in 2022, then plummeted by 72.30% to $547,000 in 2023, then skyrocketed by 36.56% to $747,000 in 2024, then plummeted by 90.90% to $68,000 in 2025.
  • Its Other financing activities was $68,000 in Q4 2025, compared to $455,000 in Q2 2025 and $1.2 million in Q1 2025.